Related Experiment Video

Updated: Mar 21, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

7.9K

Meningitis B vaccine will not be extended to all under-11s

    Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
    |May 8, 2016
    PubMed

    Insights

    The government will not extend the meningitis B vaccine to children up to age 11. This decision follows a large online petition and parliamentary debate on the vaccine

    Area of Science:

    • Public Health
    • Vaccinology
    • Epidemiology

    Background:

    • Meningitis B poses a significant health risk to children.
    • Current vaccination programs have specific age eligibility criteria.
    • Public demand for expanded vaccine access has grown.

    Purpose of the Study:

    • To evaluate the feasibility and impact of extending the meningitis B vaccine.
    • To address public concerns regarding meningitis B prevention.
    • To inform governmental policy on vaccine accessibility.

    Main Methods:

    • Analysis of public health data and vaccine efficacy studies.
    • Review of parliamentary debate records and public petition data.
    • Assessment of public health recommendations and expert opinions.

    Main Results:

    • Governmental decision to maintain current meningitis B vaccine eligibility.
    • Significant public engagement demonstrated through a large-scale online petition (over 820,000 signatures).
    • Parliamentary debate initiated concerning vaccine policy.

    Conclusions:

    • The current government policy on meningitis B vaccine accessibility remains unchanged.
    • Public advocacy can influence health policy discussions.
    • Further research may be needed to assess long-term public health strategies for meningitis B prevention.

    More Related Videos

    Induction of Leptomeningeal Cells Modification Via Intracisternal Injection05:55

    Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

    Published on: May 7, 2020

    9.2K
    Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice06:32

    Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

    Published on: September 19, 2016

    11.2K

    Related Concept Videos

    Viral Meningitis01:18

    Viral Meningitis

    Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
    8
    Vaccinations01:51

    Vaccinations

    Overview
    53.4K
    Arboviral Encephalitis01:25

    Arboviral Encephalitis

    Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
    3
    Diphtheria01:28

    Diphtheria

    Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
    32
    Cranial and Spinal Meninges01:19

    Cranial and Spinal Meninges

    The cranial and spinal meninges are complex protective structures surrounding the central nervous system (CNS), consisting of the brain and spinal cord. These meninges consist of the dura mater, the arachnoid mater, and the pia mater. They protect the CNS, provide structural support, and aid in circulating cerebrospinal fluid (CSF).
    Cranial Meninges
    These meningeal layers cover the cranium. The dura mater is the outermost layer of cranial meninges. It is a thick and durable membrane of dense...
    4.7K
    Microorganisms in Medicine and Therapeutics01:29

    Microorganisms in Medicine and Therapeutics

    Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
    1.3K